FEASIBILITY, DEVELOPMENT AND COMMERCIALIZATION AGREEMENTFeasibility, Development and Commercialization Agreement • June 22nd, 2010 • Auto Search Cars, Inc. • Pharmaceutical preparations • Delaware
This Feasibility, Development and Commercialization Agreement (this “Agreement”) is made as of July 22, 2002, by and between Voyager Pharmaceutical Corporation, a Delaware corporation with its principal place of business at 8540 Colonnade Center Drive, Raleigh, NC 27615 (“Voyager”), and Southern Biosystems, Inc., an Alabama corporation with its principal place of business at 756 Tom Martin Drive, Birmingham, Alabama 35211 (“SBS”).
AMENDMENT NO. 1 TO FEASIBILITY, DEVELOPMENT AND COMMERCIALIZATION AGREEMENTFeasibility, Development and Commercialization Agreement • June 22nd, 2010 • Auto Search Cars, Inc. • Pharmaceutical preparations • Delaware
This Amendment No. 1 to Feasibility, Development And Commercialization Agreement ("Amendment No. 1") is entered into effective January 23, 2007 (the "Amendment Date") by and between DURECT Corporation ("DURECT") and Voyager Pharmaceutical Corporation ("Voyager").
RECITALSFeasibility, Development and Commercialization Agreement • November 14th, 2002 • Durect Corp • Pharmaceutical preparations • Delaware
AMENDMENT NO. 1 TO FEASIBILITY, DEVELOPMENT AND COMMERCIALIZATION AGREEMENTFeasibility, Development and Commercialization Agreement • May 9th, 2007 • Durect Corp • Pharmaceutical preparations • Delaware
This Amendment No. 1 to Feasibility, Development And Commercialization Agreement (“Amendment No. 1”) is entered into effective January 23, 2007 (the “Amendment Date”) by and between DURECT Corporation (“DURECT”) and Voyager Pharmaceutical Corporation (“Voyager”).
